Additionally, in a mouse tumor model, the proportion of proliferating transgenic tumor-specific CD8+ T cells in TNFR2 deficient mice were significant reduced in tumor-draining lymph nodes (54). This evidence concerns the gene TNFRSF1B and neoplasm.